EUVIMEDEUVIMED entdecken
Crossref

New data inform decision‐making for breast cancer surgeries

Leah Lawrence

Cancer · 01.08.2026 · 132 (15)

DOI: 10.1002/cncr.70488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 27.07.2026. Verfasst von Leah Lawrence. Die Arbeit nennt 2 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, two studies presented at the American Society of Breast Surgeons Annual Meeting provide new comparative outcome data to assist with decision‐making for breast cancer surgeries. In addition, the HER2 ‐targeting TKI zongertinib showed a benefit in patients with advanced HER2 ‐mutant non–small cell lung cancer, and in comparison with the 2/20/20 model, use of the AQUILA criteria resulted in a 3‐fold greater number of patients with smoldering multiple myeloma who were classified as high risk.

Zitieren

APA

Lawrence, L. (2026). New data inform decision‐making for breast cancer surgeries. Cancer, 132(15). https://doi.org/10.1002/cncr.70488

Vancouver

Lawrence L. New data inform decision‐making for breast cancer surgeries. Cancer. 2026;132(15). doi:10.1002/cncr.70488

BibTeX
@article{Lawrence2026,
  author = {Lawrence, Leah},
  title = {New data inform decision‐making for breast cancer surgeries},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {15},
  doi = {10.1002/cncr.70488}
}
Kostenlos starten →